<DOC>
	<DOCNO>NCT02045212</DOCNO>
	<brief_summary>The study objectives assess change visual acuity visual field observe following administration RPh201 overall treatment period least 13 consecutive week option extend treatment phase another 13 week ( 26 week total ) , follow-up visit 3 month end treatment patient optic nerve neuropathy .</brief_summary>
	<brief_title>Safety Efficacy Study RPh201 Treatment Ischemic Optic Neuropathy ( ION ) .</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Optic Nerve Diseases</mesh_term>
	<mesh_term>Optic Neuropathy , Ischemic</mesh_term>
	<mesh_term>Optic Nerve Injuries</mesh_term>
	<criteria>1 . Participants , either men woman â‰¥ 18 year age . 2 . Diagnosis ischemic optic neuropathy unilateral bilateral : 1 . Traumatic Neuropathy 2 . Ischemic optic neuropathy Non Arteritic Ischemic Neuropathy ( NAION ) 3 . Corrected Visual acuity equal bad 6/60 visual field le 15 degree . 4 . Field view reduction 10 degree one quarter situation function . 5 . Participant understands nature procedure provide write informed consent prior study procedure . 6 . Women child bear potential must use adequate birthcontrol precaution . 1 . Glaucoma 2 . Neuropathy cause tumor . 3 . Neuropathy cause infection 4 . Mitochondrial optic neuropathy 5 . Nutritional , Radiation , Toxic optic neuropathy 6 . Retinal diabetic complication 7 . Hereditary optic neuropathy 8 . Patients complete SCOTOMA beyond three quarter . 9 . Clinical evidence presence infection . 10 . Patient receiving , receive within one month prior enrollment corticosteroid , immunosuppressive drug , cytotoxic agent , radiation therapy chemotherapy . 11 . Patient history alcohol drug abuse within last two year . 12 . Female patient pregnant nursing , childbearing potential use adequate contraception . 13 . Participation another clinical trial within 60 day prior Screening Visit study . 14 . Clinically significant and/or uncontrolled condition significant medical disease 15 . Clinically significant uncontrolled retinal disease ( AMD )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Ischemic Optic Neuropathy</keyword>
	<keyword>Traumatic Neuropathy</keyword>
	<keyword>Non Arteritic Ischemic Neuropathy ( NAION )</keyword>
</DOC>